Delivery Order SPE2DR25D2003-SPE2DR26FR04G
- Not listed
- The Defense Logistics Agency awarded a $66,545.03 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of September 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $5,358.01 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-unit package). This firm fixed-price, non-set-aside contract was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,155.29 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units). This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $14,351.01 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 10, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $12,435.22 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical product will be performed at the contractor's facility in...
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,390.33 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count supply) on September 24, 2025, with a completion date of September 25, 2025. This firm fixed price, non-set-aside contract is being performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $36,573.09 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count) on November 10, 2025, with completion targeted for November 12, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,535.89 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $52,548.97 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed price, non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR04GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,493.59 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count supply). This competitively awarded, firm fixed-price delivery order was issued on December 17, 2025, with an ultimate completion date of December 18, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement services for federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and other government entities. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs through competitively awarded delivery orders with firm fixed pricing structures. TRELEGY ELLIPTA is a combination maintenance inhaler used in respiratory disease management, representing the type of specialty pharmaceutical products the company routinely supplies through its DLA agreements to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 12/16/25 |